Genoil (GNOLF) Shares Outstanding (Diluted Average) (2018 - 2025)

Genoil (GNOLF) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $2.0 billion in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $2.0 billion, up 2.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 2.68% YoY), and the FY2025 annual result was $2.0 billion, up 2.68% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $2.0 billion in Q4 2025 per GNOLF's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $2.0 billion in Q3 2025 and troughed at $600.4 million in Q1 2021.
• A 5-year average of $1.3 billion and a median of $1.4 billion in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) surged 173.42% in 2024, then grew 2.36% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $624.0 million in 2021, then advanced by 9.04% to $680.4 million in 2022, then soared by 105.87% to $1.4 billion in 2023, then soared by 38.47% to $1.9 billion in 2024, then grew by 2.68% to $2.0 billion in 2025.
• Business Quant data shows GNOLF's Shares Outstanding (Diluted Average) at $2.0 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.